Published in J Clin Invest on August 08, 2013
Co-expression of anti-rotavirus proteins (llama VHH antibody fragments) in Lactobacillus: development and functionality of vectors containing two expression cassettes in tandem. PLoS One (2014) 0.86
RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds. Plant Cell Rep (2013) 0.80
Plant-based oral vaccines against zoonotic and non-zoonotic diseases. Plant Biotechnol J (2016) 0.80
Edible plants for oral delivery of biopharmaceuticals. Br J Clin Pharmacol (2016) 0.77
Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications. Plant Biotechnol J (2016) 0.77
The mucosal immune system: From dentistry to vaccine development. Proc Jpn Acad Ser B Phys Biol Sci (2015) 0.77
Vaccines against human diarrheal pathogens: current status and perspectives. Hum Vaccin Immunother (2014) 0.76
Potent In Vitro and In Vivo Activity of Plantibody Specific for Porphyromonas gingivalis FimA. Clin Vaccine Immunol (2016) 0.75
Infection: Rice yields new oral therapy for rotavirus infection. Nat Rev Gastroenterol Hepatol (2013) 0.75
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus. Sci Rep (2016) 0.75
Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease. PLoS One (2016) 0.75
Llama nanoantibodies with therapeutic potential against human norovirus diarrhea. PLoS One (2015) 0.75
Biotechnology: Rice-derived rotavirus antibody shows promise. Nat Rev Drug Discov (2013) 0.75
Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs. Microb Cell Fact (2015) 0.75
Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice. Front Plant Sci (2017) 0.75
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Naturally occurring antibodies devoid of light chains. Nature (1993) 7.35
Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med (2010) 6.56
Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci U S A (2006) 3.55
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
The promise of new rotavirus vaccines. N Engl J Med (2006) 2.58
Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol (1980) 2.39
Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta (1999) 2.20
Chronic rotavirus infection in immunodeficiency. J Pediatr (1980) 1.66
Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol (2000) 1.58
Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr (1992) 1.56
Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis (2007) 1.51
Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A (2007) 1.51
Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells. J Virol (1991) 1.49
Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43
Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol (1998) 1.37
Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis (2005) 1.36
A simple set of plasmids for the production of transgenic plants. Biosci Biotechnol Biochem (2010) 1.32
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis (2006) 1.31
Rotavirus overview. Pediatr Infect Dis J (2009) 1.28
A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci U S A (2005) 1.24
Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom. Emerg Infect Dis (2010) 1.23
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol (2006) 1.22
Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine (2006) 1.20
Post-translational modifications of recombinant proteins: significance for biopharmaceuticals. Mol Biotechnol (2008) 1.18
Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J Virol (2002) 1.18
Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J Virol (2008) 1.15
Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J (1998) 1.14
Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. J Allergy Clin Immunol (2009) 1.14
Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. Mass Spectrom Rev (2007) 1.14
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci U S A (2010) 1.11
Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. J Clin Microbiol (1987) 1.10
Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr (2001) 1.10
Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection. J Virol (2002) 1.10
Foreign gene products can be enhanced by introduction into low storage protein mutants. Plant Biotechnol J (2003) 1.08
Temporal perturbation of tyrosine phosphoproteome dynamics reveals the system-wide regulatory networks. Mol Cell Proteomics (2008) 1.07
Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Proteins (2005) 1.04
Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs. J Infect Dis (2010) 1.01
Rotavirus-associated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Pediatr Infect Dis J (2001) 1.01
High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. Biotechnology (N Y) (1995) 1.00
Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr (1988) 0.98
Persistent rotavirus vaccine shedding in a new case of severe combined immunodeficiency: A reason to screen. J Allergy Clin Immunol (2010) 0.95
Structures of rotavirus reassortants demonstrate correlation of altered conformation of the VP4 spike and expression of unexpected VP4-associated phenotypes. J Virol (2003) 0.93
Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea. Future Microbiol (2011) 0.93
Serial observations of chronic rotavirus infection in an immunodeficient child. Microbiol Immunol (1991) 0.93
Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant (2005) 0.92
A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity. J Immunol (2009) 0.91
Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification. Plant Biotechnol J (2013) 0.91
In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS One (2012) 0.89
A cluster of rotavirus enteritis in adult transplant recipients. Transpl Int (2005) 0.83
Production and characterization of anti-(mucin MUC1) single-domain antibody in tobacco (Nicotiana tabacum cultivar Xanthi). Biotechnol Appl Biochem (2007) 0.83
RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine. Vaccine (2012) 0.82
Highly efficient targeting and accumulation of a F(ab) fragment within the secretory pathway and apoplast of Arabidopsis thaliana. Eur J Biochem (2001) 0.79
Transmission of rotavirus diarrhea in a bone marrow transplantation unit by a hospital worker. Bone Marrow Transplant (1991) 0.78
Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet (2003) 7.98
Escape of intracellular Shigella from autophagy. Science (2004) 6.64
Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol (2008) 5.10
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science (2002) 4.38
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (2012) 4.20
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature (2009) 3.18
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2011) 3.05
CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol (2006) 3.04
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol (2007) 2.98
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci U S A (2004) 2.75
Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol (2002) 2.57
Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc Natl Acad Sci U S A (2007) 2.44
Single-domain antibody fragments with high conformational stability. Protein Sci (2002) 2.31
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A (2009) 2.31
Generation of HIV latency in humanized BLT mice. J Virol (2011) 2.20
Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12
Breast conserving surgery using volume replacement with oxidized regenerated cellulose: a cosmetic outcome analysis. Breast J (2014) 2.06
Comprehensive expression profiling of rice grain filling-related genes under high temperature using DNA microarray. Plant Physiol (2007) 2.03
Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest (2003) 2.02
A cohort study to examine whether time and risk preference is related to smoking cessation success. Addiction (2009) 1.96
Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood (2011) 1.96
B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A (2009) 1.95
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet (2012) 1.94
Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet (2007) 1.87
Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J Exp Med (2005) 1.84
RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol (2009) 1.73
Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells. Immunity (2002) 1.70
Genome-wide analysis in German shepherd dogs reveals association of a locus on CFA 27 with atopic dermatitis. PLoS Genet (2013) 1.69
Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog (2012) 1.68
Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci U S A (2010) 1.67
Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat Commun (2012) 1.64
Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature (2010) 1.63
Anti-rotavirus protein reduces stool output in infants with diarrhea: a randomized placebo-controlled trial. Gastroenterology (2013) 1.63
Assembly and budding of Ebolavirus. PLoS Pathog (2006) 1.62
Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One (2008) 1.61
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission. PLoS Pathog (2015) 1.61
Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol (2004) 1.60
High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation. Circ J (2010) 1.60
European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups. Mol Med (2009) 1.59
Guidelines for newborn screening of primary immunodeficiency diseases. Curr Opin Hematol (2013) 1.59
Comprehensive gene expression profiling of Peyer's patch M cells, villous M-like cells, and intestinal epithelial cells. J Immunol (2008) 1.58
Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. J Cell Sci (2007) 1.57
Simultaneous tracking of capsid, tegument, and envelope protein localization in living cells infected with triply fluorescent herpes simplex virus 1. J Virol (2008) 1.56
In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol (2002) 1.55
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med (2009) 1.53
Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A (2007) 1.51
Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol (2009) 1.49
A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med (2007) 1.47
Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun (2005) 1.46
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater (2010) 1.45
Transmission events within outbreaks of gastroenteritis determined through analysis of nucleotide sequences of the P2 domain of genogroup II noroviruses. J Clin Microbiol (2008) 1.43
FBXL21 regulates oscillation of the circadian clock through ubiquitination and stabilization of cryptochromes. Cell (2013) 1.42
Suppression of lens growth by alphaA-crystallin promoter-driven expression of diphtheria toxin results in disruption of retinal cell organization in zebrafish. Dev Biol (2003) 1.42
Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol (2002) 1.42
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health (2003) 1.42
Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease. Clin Infect Dis (2012) 1.41
Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J Virol (2007) 1.40
Diversity of translation start sites may define increased complexity of the human short ORFeome. Mol Cell Proteomics (2007) 1.39
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J (2009) 1.39
Specific expression of apolipoprotein A-IV in the follicle-associated epithelium of the small intestine. Dig Dis Sci (2014) 1.38
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol (2010) 1.36